ZOLL RESPICARDIA INC

ZOLL RESPICARDIA INC specializes in the design, development, and manufacturing of advanced implantable cardiac and neuromodulation devices, including implantable pulse generators, stimulation leads, and life-sustaining prosthetic systems. Their technical expertise centers on precision medical instrumentation for cardiac rhythm management, neurostimulation, and wearable cardiac monitoring, with a focus on biocompatible materials, low-power embedded systems, and FDA-regulated device validation. The company demonstrates deep specialization in minimally invasive implantable technologies, particularly in delivering next-generation pulse generators and lead-based stimulation systems that meet stringent clinical and regulatory standards for long-term patient safety and performance. The contractor maintains a consistent, primary relationship with the Department of Veterans Affairs, supplying critical cardiac and prosthetic implant systems to support veteran healthcare needs. Their work for the VA centers on high-acuity, life-critical devices such as pacemakers, defibrillators, and wearable cardiac monitors, indicating a trusted role in sustaining long-term patient care within the VA’s cardiac intervention and rehabilitation programs. The company’s industry focus is firmly anchored in surgical and medical instrument manufacturing (NAICS 339112) and surgical appliance and supplies manufacturing (NAICS 339113), positioning them as a niche supplier of Class III implantable medical devices within the federal healthcare supply chain. Their market presence is defined by engineering rigor in cardiac rhythm management and neuromodulation technologies, serving a highly regulated segment requiring validated manufacturing processes and traceable quality systems. As a 2L entity headquartered in Minnetonka, Minnesota, ZOLL RESPICARDIA INC operates as a mid-tier manufacturer with no disclosed federal certifications. Their geographic footprint supports federal medical procurement through a dedicated R&D and production facility, reinforcing their role as a reliable provider of mission-critical cardiac implant systems to government healthcare providers.